OTCMKTS:ENOBEnochian Biosciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Enochian Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.92 +0.15 (+3.98 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range$3.82Now: $3.92▼$3.9950-Day Range$3.46MA: $3.89▼$6.0652-Week Range$1.95Now: $3.92▼$13.43Volume55,900 shsAverage Volume259,749 shsMarket Capitalization$182.27 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Enochian Biosciences Inc., a biopharmaceutical company, identifies, develops, manufactures, and commercializes gene therapies for HIV/AIDS and cancer patients. Its lead candidate include ENO-1001 a genetically modified cell therapy for patients with HIV/AIDS. It is also developing ENO-2001, an HIV vaccine; and additional compounds, such as ENO-4001, ENO-4002, ENO-3001, and ENO-5001 that are in discovery stage for prevention of relapse in colon cancer patients. Enochian BioSciences is headquartered in Los Angeles, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Enochian Biosciences. Previous Next 2.6 Community Rank Outperform VotesEnochian Biosciences has received 23 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEnochian Biosciences has received 21 “underperform” votes. (Add your “underperform” vote.)Community SentimentEnochian Biosciences has received 52.27% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Enochian Biosciences and other stocks. Vote “Outperform” if you believe ENOB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ENOB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEnochian Biosciences does not currently pay a dividend.Dividend GrowthEnochian Biosciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Enochian Biosciences insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ENOB Previous Symbol CUSIPN/A CIKN/A Webwww.enochianbio.com Phone510-203-4857Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares46,497,000Market Cap$182.27 million Next Earnings DateN/A OptionableNot Optionable OTC:ENOB Rates by TradingView Receive ENOB News and Ratings via Email Sign-up to receive the latest news and ratings for ENOB and its competitors with MarketBeat's FREE daily newsletter. Enochian Biosciences (OTCMKTS:ENOB) Frequently Asked Questions How has Enochian Biosciences' stock been impacted by COVID-19 (Coronavirus)? Enochian Biosciences' stock was trading at $2.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ENOB stock has increased by 74.2% and is now trading at $3.92. View which stocks have been most impacted by Coronavirus. How were Enochian Biosciences' earnings last quarter? Enochian Biosciences Inc (OTCMKTS:ENOB) announced its quarterly earnings data on Monday, May, 11th. The company reported ($0.03) EPS for the quarter. View Enochian Biosciences' earnings history. Has Enochian Biosciences been receiving favorable news coverage? Press coverage about ENOB stock has trended neutral recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Enochian Biosciences earned a daily sentiment score of 0.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Enochian Biosciences. Who are some of Enochian Biosciences' key competitors? Some companies that are related to Enochian Biosciences include Aptose Biosciences (APS), Oxford BioMedica (OXB), CEL-SCI (CVM), Cel-Sci (CVM), Paradigm Biopharmaceuticals (PAR), SIGA Technologies (SIGA), Biotest (BIO), Neptune Wellness Solutions (NEPT), TELIX Pharmaceutical (TLX), Starpharma (SPL), Silence Therapeutics (SLN), Altimmune (ALT), ProMetic Life Sciences (PLI), Pfenex (PFNX) and IMV (IMV). View all competitors. What other stocks do shareholders of Enochian Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Enochian Biosciences investors own include Huntington Bancshares (HBAN), AbbVie (ABBV), Algonquin Power & Utilities (AQN), BCE (BCE), BlackRock Resources and Commodities (BCX), Franklin Resources (BEN), Blackrock Enhanced Internationl Dvdnd Tr (BGY), Bank of Nova Scotia (BNS), BlackRock Enhanced Global Dividend Trust (BOE) and British American Tobacco (BTI). What is Enochian Biosciences' stock symbol? Enochian Biosciences trades on the OTCMKTS under the ticker symbol "ENOB." How do I buy shares of Enochian Biosciences? Shares of ENOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Enochian Biosciences' stock price today? One share of ENOB stock can currently be purchased for approximately $3.92. How big of a company is Enochian Biosciences? Enochian Biosciences has a market capitalization of $182.27 million. What is Enochian Biosciences' official website? The official website for Enochian Biosciences is www.enochianbio.com. How can I contact Enochian Biosciences? The company can be reached via phone at 510-203-4857. This page was last updated on 7/12/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
